GlassScriptPhysician profile
Constance Q Zhou
NPI 1447453055
$3,242.89
in general payments reported to CMS, 2019-2025
26 companies · $394 in 2025
The $394 reported for 2025 was more than what a typical Otolaryngology provider received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $384 · 2020: $805 · 2021: $313 · 2022: $220 · 2023: $580 · 2024: $547 · 2025: $394.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,335 · Education: $186.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,335.25 |
| Education | $185.98 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aerin Medical INC. | $581.01 | 2020-2023 | |
| Genzyme Corporation | $546.57 | 2021-2025 | |
| Regeneron Healthcare Solutions, INC. | $381.35 | 2021-2025 | Dupixent |
| Stryker Corporation | $303.99 | 2019-2022 | |
| Inspire Medical Systems, INC. | $206.24 | 2023-2025 | Inspire |
| Optinose US, INC. | $205.58 | 2019-2023 | |
| Acclarent, INC | $159.21 | 2019-2020 | |
| Sanofi-Aventis U.S. LLC | $151.98 | 2023-2024 | |
| Glaxosmithkline, LLC. | $95.54 | 2022-2024 | Nucala |
| Alk-Abello, INC | $89.24 | 2020-2025 | Alternaria Tenuis, Histamine Positive, Standardized Mite D. Farinae |
| Medtronic, INC. | $83.06 | 2024-2025 | Propel, Novapak |
| Kaleo, INC. | $54.58 | 2020-2021 | |
| Hikma Pharmaceuticals USA | $54.27 | 2022-2024 | Ryaltris |
| Covidien LP | $43.73 | 2020 | |
| Merck Sharp & Dohme LLC | $35.87 | 2021-2023 |
Show all 26 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Karl Storz Endoscopy-America | $34.06 | 2025 | |
| Amgen INC. | $34.00 | 2025 | |
| Astrazeneca Pharmaceuticals LP | $30.89 | 2025 | Tezspire |
| Med-El Corporation | $30.59 | 2023 | Bci 602 Kit |
| Takeda Pharmaceuticals U.S.A., INC. | $28.90 | 2023 | Cuvitru |
| Intersect Ent, INC. | $27.38 | 2019 | |
| Hologic Sales and Service, LLC | $14.71 | 2024 | Coolseal Generator |
| Phadia US INC. | $13.74 | 2021 | |
| Shire North American Group INC | $13.32 | 2019 | |
| Arbor Pharmaceuticals, INC. | $11.71 | 2019 | |
| Olympus America INC. | $11.37 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Constance Zhou listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.